Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.


Rx Item-Betamethasone Sodium Phosphate USP 5gm By Letco Medical

Betamethasone Sodium Phosphate, USP 5gm By Letco Medical Item No.Letco684557 NDC No. 62991-1024-02 62991102402 Category: Rx This Prescription Item Can Only Be Ordered By Physicians, Pharmacies, DentisJust change the quantity and save!Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.COMPOUNDING ITEMS SPECIALIST

Rx Item-Betamethasone Sodium Phosphate USP 5gm By Letco Medical

$1272.00$635.93

Item No.:RX-LETCO684557, Betamethasone Sodium Phosphate, USP 5gm By Letco Medical Item No.Letco684557 NDC No. 62991-1024-02 62991102402 Category: Rx This Prescription Item Can Only Be Ordered By Physicians, Pharmacies, Dentists, Wholesalers, Hospitals, Government, Va, Physician Assistants, Nurse Practitioners , Podiatrists, Opticians, Optometrists, Veterinarians, Naturalists, Licensed Labs, Physical Therapists & Pharmacists In Their Scope Of Practice. UPC No.: 22100010202900

Have a question?

BETAMETHASONE SODIUM PHOSPHATE, USP 5GM by Letco Medical Safety Data Sheet Section 1: Identification Common Name/Trade Name BETAMETHASONE SODIUM PHOSPHATE USP Supplier Information Letco Medical, LLC 1316 Commerce Drive NW Decatur, AL 35601 1 (800) 239-5288 +1 (734) 843-4693 IN CASE OF EMERGENCY: Chemtrec 1 (800) 424-9300 (24 hours) Product Synonym(s) Betamethasone 21-phosphate disodium salt Relevant Use(s) of Product Manuf acture or Compounding of Substances Section 2: Hazards Identification Classification of Substance or Mixture Acute toxicity, Oral (Category 4), Acute toxicity, Inhalation (Category 2), Serious eye damage/eye irritation (Category 2B), Reproductive toxicity (Category 2), Specif ic target organ toxicity, repeated exposure (Category 1) (endochrine system) Signal Word Danger Hazard Statement(s) H302 Harmf ul if swallowed H320 Causes eye irritation H330 Fatal if inhaled H361 Suspected of damaging f ertility or the unborn child H372 Causes damage to organs through prolonged or repeated exposure Pictogram(s) Precautionary Statement(s) P201 Obtain special instructions bef ore use. P202 Do not handle until all saf ety precautions have been read and understood. P260 Do not breathe dust/f ume/gas/mist/vapours/spray. P264 Wash hands thoroughly af ter handling. P271 Use only outdoors or in a well-ventilated area. P280 Wear protective gloves/protective clothing/eye protection/f ace protection. P284 Wear respiratory protection. P301+P312 IF SWALLOWED Call a POISON CENTER or doctor/physician if you f eel unwell. P304 IF INHALED P305+P351+P338 IF IN EYES Rinse cautiously with water f or several minutes. Remove contact lenses if present and easy to do. continue rinsing. P308+P313 IF exposed or concerned Get medical advice/attention. P310 Immediately call a POISON CENTER or doctor/physician. P330 Rinse mouth. P337+P313 If eye irritation persists Get medical advice/attention. P403+P233 Store in a well ventilated place. Keep container tightly closed. P405 Store locked up. P501 Dispose of contents/container to an approved waste disposal plant. Hazards Not Otherwise Classified No data available Ingredient(s) with Unknown Toxicity No data Available Section 3: Composition/Information on Ingredients Chemical Name Pregna-1,4-diene-3,20-dione, 9-f luoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, disodium salt, (11beta,16beta)- Common Name Betamethasone Sodium Phosphate CAS Number 151-73-5 Impurities and/or Stabilizing Additives No data available Page 1 of 5 Section 4: First Aid Measures General Advice Remove from exposure. Remove contaminated clothing. For treatment advice, seek guidance from an occupational health physician or other licensed health-care provider f amiliar with workplace chemical exposures. In the United States the national poison control center phone number is 1-800-222-1222. If person is not breathing, give artif icial respiration. If breathing is dif f icult, give oxygen if available. Persons developing serious hypersensitivity (anaphylactic) reactions must receive immediate medical attention. If Inhaled Remove victim to fresh air and keep at rest in a position comf ortable f or breathing. Oxygen or artif icial respiration if needed. Do not use mouth to mouth method if the victim inhales the substance. Induce artif icial respiration with the aid of pocket mask equipped with a one-way valve or other proper respiratory medical device. Call a physician or poison control center immediately. In Case of Skin Contact Rinse skin with water/shower. Get medical attention if irritation develops and persists. In Case of Eye Contact Rinse eyes cautiously with water f or several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Get medical attention if irritation develops and persist. If Swallowed IF SWALLOWED: Call POISON CENTER or doctor/physician if you f eel unwell. Rinse mouth. Most Important Symptoms and Effects Irritation of eyes an mucous membranes. Treatment of corticoseroid overdose should be symptomatic and supportive and may include the f ollowing: Toxicity is low af ter acute ingestion. Gastrointestinal decontamination is general not necessary. (Poisindex). Section 5: Fire Fighting Measures Suitable Extinguishing Media Use f ire-extinguishing media appropriate f or surrounding materials. Water. Foam. Dry chemical or CO2. Special Hazards Arising From the Substance/Mixture No unusual f ire or explosion hazards noted. Special PPE and/or Precautions for Firefighters Wear suitable protective equipment. Section 6: Accidental Release Measures Personal Precautions, Protective Equipment and Emergency Procedures Use water spray to cool unopened containers. As with all f ires, evacuate personnel to a saf e area. Firef ighters should use self-contained breathing equipment and protective clothing. Use standard f iref ighting procedures and consider the hazards of other involved materials. Keep unnecessary personnel away. Do not touch damaged containers or spilled material unless wearing appropriate protective clothing. Ensure adequate ventilation. Avoid inhalation of dust from the spilled material. Wear appropriate personal protective equipment. Methods and Materials Used for Containment Sweep up or vacuum up spillage and collect in suitable container f or disposal. Avoid the generation of dusts during clean-up. For waste disposal, see section 13 of the SDS. Clean surf ace thoroughly to remove residual contamination. Cleanup Procedures Sweep up or vacuum up spillage and collect in suitable container f or disposal. Avoid the generation of dusts during clean-up. For waste disposal see section 13 of the SDS. Clean surf ace thoroughly to remove residual contamination. Section 7: Handling and Storage Precautions for Safe Handling As a general rule, when handling chemicals, avoid all contact and inhalation of dust, mist, and/or vapors associated with the material. Clean equipment and work surf aces with suitable detergent or solvent af ter use. Af ter removing gloves, wash hands and other exposed skin thoroughly. Use of designated area is recommended f or handling of potent materials. Conditions for Safe Storage Store in tight container as def ined in the USP-NF. This material should be handled and stored per label instructions to ensure product integrity. Page 2 of 5 Section 8: Exposure Controls/Personal Protection Components with Workplace Control Parameters No exposure standards allocated. Appropriate Engineering Controls Airborne exposures should be controlled primarily by engineering controls such as general dilution ventilation, local exhaust ventilation, or process enclosure. Local exhaust ventilation is generally pref erred to general exhaust because it can control the contaminant at its source, preventing dispersion into the work area. And industrial hygiene survey involving air monitoring may be used to determine the ef f ectiveness of engineering controls. Ef f ectiveness of engineering controls intended f or use with highly potent materials should be assessed by use on nontoxic surrogate materials. Local exhaust ventilation such as laboratory f ume hood or other vented enclosure is recommended, particularly f or grinding, crushing, weighing, or other dust-generating procedures. Handle in accordance with good industrial hygiene and saf ety practice. PPE - Eye/Face Protection Saf ety glasses with side shields are recommended. Face shields or goggle may be required if splash potential exits or if corrosive materials are present. Approved eye protection is pref erred. Maintain eyewash f acilities in the work area. PPE - Skin Protection Chemically compatible gloves. For handling solutions, ensure that the glove material is protective against the solvent being used. Use handling practices that minimize direct hand contact. Employees who are sensitive to natural rubber (latex) should use nitrile or synthetic nonlatex gloves. Use of powdered latex gloves should be avoided du to the risk of latex allergy. To reduce the risk of contamination of skin and surf aces, wear two pairs of gloves. Remove the outer gloves af ter handling and cleanup of the material, and remove the inner gloves only af ter removing other personal protective equipment. PPE - Body Protection Chemically compatible gloves. For handling solutions, ensure that the glove material is protective against the solvent being used. Use handling practices that minimize direct hand contact. Employees who are sensitive to natural rubber (latex) should use nitrile or other synthetic nonlatex gloves. Use of powdered latex gloves should be avoided due to risk of latex allergy. To reduce the risk of contamination of skin and surf aces, wear two pairs of gloves. Remove the outer gloves af ter handling and cleanup material, and remove the inner gloves only af ter removing other personal protective equipment. Other: For handling of laboratory scale quantities, a disposable lab coat or isolation gown over street clothes is recommended. Where signif icant quantities are handled, work clothing and booties may be necessary to prevent take-home contamination. PPE - Respiratory Protection Where respirators are deemed necessary to reduce or control occupational exposures, use NIOSH-approved respiratory protection and have an ef f ective respirator program in place. (applicable U.S. regulation OSHA 29 CFR 1910.134) Section 9: Physical and Chemical Properties Appearance Form: Powder Physical state: Solid Colour: White to creamy white powder Upper/Lower Flammability or Explosive Limits No data available Odor Odorless Vapor Pressure < 0.0000001 kPa at 25 �C Odor Threshold No data available Vapor Density No data available pH 7.5 - 9 (1% solution) Relative Density No data available Melting Point/Freezing Point No data available Solubility Solubility in water: Freely soluble Initial Boiling Point and Boiling Range No data available Flash Point No data available Evaporation Rate No data available Flammability (Solid, Gas) No data available Partition Coefficient No data available Auto-Ignition Temperature No data available Decomposition Temperature No data available Viscosity No data available Section 10: Stability and Reactivity Reactivity No reactivity hazards known. Chemical Stability Stable under normal conditions. Possibility of Hazardous Reactions No dangerous reaction known under conditions of normal use. Conditions to Avoid No data available Incompatible Materials Acids. Bases. Oxidizing agents. Reducing agents. Hazardous Decomposition Products Irritating and/or toxic f umes or gases. Emits toxic f umes under f ire conditions. Pox. F-NaOx Page 3 of 5 Section 11: Toxicological Information Acute Toxicity - LD50 Oral LD50 Oral Mouse 1607 mg/kg Rat 1877 mg/kg Acute Toxicity - Inhalation LC50 Rat 0.071 - 0.73 mg/l Acute Toxicity - Dermal No data available Acute Toxicity - Eye Causes eye irritation. Skin Corrosion/Irritation Based on available data, the classif ication criteria are not met. Serious Eye Damage/Irritation Causes eye irritation. Respiratory or Skin Sensitazation Based on the available data, the classif ication criteria are not met. Germ Cell Mutagenicity Data from germ cell mutagenicity tests were not f ound. Due to lack of data the classif ication is not possible. Carcinogenicity IARC Due to lack of data the classif ication is not possible. This material is not considered to be a carcinogen by IARC. Carcinogenicity ACGIH Due to lack of data the classif ication is not possible. This material is not considered to be carcinogen by ACGIH. Carcinogenicity NTP Due to lack of data the classif ication is not possible. This material is not considered to be carcinogen by NTP. Carcinogenicity OSHA Due to lack of data the classif ication is not possible. This material is not considered to be a carcinogen by OSHA. Reproductive Toxicity Suspected of damaging f ertility or the unborn child. Most studies have concluded that therapeutic use of corticosteroids by pregnant women does not cause adverse ef f ects on the f etus. A small increase in the incidence of clef t palate was seen in some human studies. Inf ants born to mothers who received substantial dosed of corticosteroids during pregnancy should be observed f or signs of hypoadrenalism. Specific Target Organ Toxicity - Single Exposure Due to lack of data the classif ication is not possible. Specific Target Organ Toxicity - Repeated Exposure Causes damage to organs (endocrine system) through prolonged or repeated exposure. Aspiration Hazard Based on available data, the classif ication criteria are not met. Section 12: Ecological Information Toxicity No ecotoxicity data noted f or the ingredients. Persistence and Degradability No data available Bio-accumulative Potential No data available Mobility in Soil No data available Other Adverse Effects No data available Section 13: Disposal Considerations Waste Treatment Methods Product Dispose in accordance with all applicable regulations. Under RCRA, it is the responsibility of the user of the product to determine, at the time of disposal, whether the product meets RCRA criteria f or hazardous waste. Waste Treatment Methods Packaging Dispose of in accordance with local regulations. Empty containers or liners may retain some product residues. This material and its container must be disposed or in a saf e manner (see: Disposal instructions). Special Precautions Landfill or Incinerations Empty containers should be taken to an approved waste handling site f or recycling or disposal. Since emptied containers may retain product residue, f ollow label warnings even af ter container is emptied. Other Information No data available Section 14: Transport Information UN Number UN Proper Shipping Name Transport Hazard Class(es) Packaging Group Environmental Hazards No data available Section 15: Regulatory Information CERCLA/SARA Hazardous Substances - Not applicable. Superf und Amendments and Reauthorization Act of 1986 (SARA) Hazard categories Immediate Hazard - Yes Delayed Hazard - No Fire Hazard - No Pressure Hazard - No Reactivity Hazard - No SARA 302 Extremely Hazardous substance: No SARA 311/312 Hazardous chemical: No Other f ederal regulations: Saf e Drinking Water Act (SWDA) Not regulated. Food and Drug Administration (FDA) Not regulated. US State regulations: Calif ornia Saf e Drinking Water and Toxic Enf orcement Act of 1986 (Proposition 65): This material is not know to contain any chemicals currently listed as carcinogens or reproductive toxins. Issue Date 08/18/2010 Revision Date 02/12/2014. Page 4 of 5 Section 16: Other Information Additional Information Prepared By Lisa Russell Revision Date 01/15/2019 14:24 Disclaimer Letco Medical, LLC believes that the above information is correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. If the product is used as a component in another product, this information may not be applicable. NO WARRANTY OF FITNESS FOR ANY PARTICULAR PURPOSE, WARRANTY OF MERCHANTABILITY OR ANY OTHER WARRANTY, EXPRESSED OR IMPLIED, IS MADE CONCERNING THE INFORMATION PROVIDED ABOVE. Letco Medical shall not be held liable for any loss or damage resulting from handling, storage, use or from contact with the above product. Page 5 of 5

Betamethasone Sodium Phosphate, USP 5gm By Letco Medical Item No.Letco684557 NDC No. 62991-1024-02 62991102402 Category: Rx This Prescription Item Can Only Be Ordered By Physicians, Pharmacies, Dentis
BETAMETHASONE SODIUM PHOSPHATE, USP 5GM
Betamethasone Sodium Phosphate, USP 5gm By Letco Medical Item No.Letco684557 NDC No. 62991-1024-02 62991102402 Category: Rx This Prescription Item Can Only Be Ordered By Physicians, Pharmacies, Dentis

Just change the quantity and save!
Buy more Save More!
Just change the quantity and save!

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

COMPOUNDING ITEMS SPECIALIST
LETCO MEDICAL
COMPOUNDING ITEMS SPECIALIST